Morgan Stanley Maintains Overweight on Danaher, Lowers Price Target to $255

Benzinga Newsdesk www.benzinga.com Negative 74.5%

Neg 74.5% Neu 0% Pos 0%

Morgan Stanley analyst Kallum Titchmarsh maintains Danaher (NYSE:DHR) with a Overweight and lowers the price target from $270 to $255.